Skip Navigation


Age and Ageing Advance Access originally published online on May 5, 2008
Age and Ageing 2008 37(4):464-467; doi:10.1093/ageing/afn091
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
37/4/464    most recent
afn091v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Koloski, N. A.
Right arrow Articles by Dobson, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koloski, N. A.
Right arrow Articles by Dobson, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © The Author 2008. Published by Oxford University Press on behalf of the British Geriatrics Society.

Performance of the Goldberg Anxiety and Depression Scale in older women

SIR—The exact nature of the relationship between anxiety and depression in older people remains unclear, as evidence suggests that older adults are more likely than younger adults to manifest mixed anxiety and depression [1–4]. There is a frequent co-occurrence of anxiety and depression in older people in community-based studies, clinical settings and in institutions [5,6]. Data also suggest that the distinctive features of anxiety and depression become less pronounced with increasing age [7], and that the experience of anxiety and depression may in fact differ qualitatively with increasing age [8].

The Goldberg Anxiety and Depression Scale (GADS) is an 18-item self-report symptom inventory that was developed by Goldberg and colleagues from 36 items in the Psychiatric Assessment Schedule [9]. The GADS has been used in several studies of community-dwelling older adults [10]. McKinnon et al. (1994) [7] administered it to 832 older community-dwelling residents from Canberra, Australia (mean age = 76 years, SD = 4.9). Latent trait analyses demonstrated that the GADS items defined two correlated dimensions of anxiety and depression, with a third sleep disturbance factor also detected [7]. Christensen et al. (1999) [8] used structural equation modelling and found anxiety and depression to be highly correlated but distinct entities.

More recently, Schoevers et al. (2003) [11] evaluated a sample of 4051 older community-dwelling persons living in Amsterdam. Using clinical psychiatric diagnoses [12] they demonstrated support for a single continuous-scale variable comprising both generalised anxiety disorder and depression, with mixed anxiety-depression representing the most severe end of the continuum.

We aim to extend previous work with the GADS by exploring the relationship between anxiety and depression in a large-scale national population sample of older Australian women.

Methods

Participants
Participants were selected from the older cohort of The Australian Longitudinal Study on Women's Health (ALSWH), which has been running since 1996. Characteristics of the participants have been described elsewhere [13]; details of attrition over time (in this age group mainly through death or frailty) have been given by Lee et al. (2005) [14]. This analysis is based on data from the third survey of the older cohort conducted in 2002 when the women were aged 75–80 years.

Measures
The GADS score is based on responses of ‘yes’ or ‘no’ to nine depression and nine anxiety items, asking how respondents have been feeling in the past month. Goldberg et al. (1988) considered patients with anxiety scores of 5 or more or with depression scores of 2 or more as having a 50% chance of a clinically important disturbance [10].

General mental health was measured using the Australian standard version of the Medical Outcomes Study SF-36, a widely used measure of self-reported health [15,16]. Five items from the general mental health sub-scale (MH) were used in this analysis [17]. The anxiety items used from this scale were ‘Have you been a very nervous person?’ and ‘Have you felt calm and peaceful?’ The depression items were ‘Have you felt so down in the dumps that nothing could cheer you up?’, ‘Have you felt down?’ and ‘Have you been a happy person?’. Responses are coded from 1 to 6 and summed to give separate scores for anxiety and depression. Participants with scores in the top deciles for anxiety and depression separately were arbitrarily considered to meet criteria for these conditions.

Self-reported medical conditions and medications prescribed were also incorporated. These included responses to the questions such as: ‘In the last 3 years have you been diagnosed with or treated for ...’, followed by a list of conditions which included ‘anxiety/nervous disorder’ and ‘depression’.

Data analyses
The dimensionality of responses to the GADS was examined using latent trait analysis for binary responses performed using NOHARM87 [18]. This method was also used by Goldberg et al. [9] and Mackinnon et al. [7]. Factor loadings from latent trait analysis can be interpreted in a similar way to loadings obtained from conventional factor analysis for continuous-scale responses, and factor loadings can be similarly rotated to assist interpretation [19].

Exploratory analysis forcing one, two and three dimensions was conducted. The two- and three-factor solutions were rotated using the PROMAX method [19]. Confirmatory analysis was performed with the nine anxiety and nine depression items proposed by Goldberg et al. [9], set to load on separate but correlated factors with item loadings on the alternative factor set to zero. Goodness-of-fit of the latent trait models was summarised by the root mean square of residuals and Tanaka's index [20]. For the root mean square of residuals, zero indicates a perfect fit and larger values indicate poorer fit. The reverse is true for Tanaka's index zero, with values exceeding 0.8 considered an acceptable fit. Cronbach's alpha was used to assess the extent to which items could be regarded as measuring a single latent variable.

Results

Numbers of respondents
Of the 12,432 women initially recruited into the study, 90% (10,434) who were eligible responded to Survey 2 and 85% (8,647) responded to Survey 3. Most of the data reported here are from the 7,264 women who completed all 18 GADS items (1,383 or 16% missed at least one of these items).

Responses to GADS items
The percentage of women responding with a ‘yes’ to GADS items ranged from 7 to 62%; the percentage missing any one item ranged from 2 to 4%.

Latent trait analysis
Results from exploratory and confirmatory latent trait analysis are shown in Table 1. For the one-dimensional solution all items had moderate to high loadings. The two-dimensional solution suggested that 15 anxiety and depression items formed one factor, and 3 sleep-related items formed the other factor. The correlation between these two factors was 0.60. The three-dimensional solution suggested that 4 anxiety items formed one factor, 11 depression (and anxiety) items formed a second factor and 3 sleep-related items formed a third factor. There was high correlation (0.76) between the first two dimensions, and moderate correlation between these and the sleep-related dimension (0.45 and 0.46). For all exploratory analyses of the GADS items relating to ‘headaches or neck aches’, ‘lost weight/poor appetite’ and ‘waking early’ had the lowest loadings (below 0.5).


View this table:
[in this window]
[in a new window]

 
Table 1. Exploratory and confirmatory latent trait analyses of GADS: factor loadings for 1, 2 and 3 dimensions for the Goldberg anxiety and depression scale, for n = 7, 264 women who responded to all 18 items in Survey 3 (loadings greater than 0.40 are shown in bold)

 
All models fit the data very well. Improvements in fit from the one- to the two-dimensional, and from the two- to the three-dimensional solutions were not substantial. High correlations between factors for the higher-order solutions support the optimality of the one-dimensional solution.

The confirmatory latent trait solution fitted almost as well as the one-dimensional solution from the exploratory analysis (Table 1). Thus, the confirmatory analysis did not support the separation of the anxiety and depression sub-scales. There was substantial correlation between the various GADS sum scores. For example, the sum score of all items was highly correlated with the anxiety sub-scale (0.93) and the depression sub-scale (0.89).

GADS versus other measures of anxiety and depression
More women met the criteria for both anxiety and depression (13.1%) using the GADS compared with self-reported doctor diagnosis (1.9%), medication usage (4.3%) or SF-36 sub-scale (5.4%) (see Table 2). For anxiety alone, there was poor agreement between GADS and the other measures with kappa values of –0.13 to 0.28; for depression alone also agreement was poor with values of 0.02 to 0.10.


View this table:
[in this window]
[in a new window]

 
Table 2. Prevalence of anxiety and/or depression using the GADS and other measures for n = 7, 264 women who responded to all 18 items in Survey 3

 
Discussion

This study provides support for the proposition that anxiety and depression in older women may be viewed as a unitary construct. Anxiety and depression dimensions of the GADS were highly correlated, suggesting they measure the same or very similar concepts. Our results confirm those of McKinnon et al. [7] who assessed the GADS in a smaller sample of older Australian males and females, but differ from those of Goldberg et al. [10] who found high sensitivity for both the anxiety and depression scales in a much younger sample of medical patients in the United Kingdom using clinical criteria as the gold standard.

Our data adds further support to speculation that there are qualitative differences in the expression and co-morbidity of anxiety and depression in later life. Previous studies have shown that older adults are more likely than younger adults to manifest a mixture of anxiety and depression [1–4] while the distinctive features of anxiety and depression may become less pronounced with increasing age [7].

Another potential explanation for the high correlation between anxiety and depression in the GADS could be the higher prevalence (13%) of a possible mixed anxiety-depression syndrome in our sample relative to other samples. Schoevers et al. [11] found a prevalence of mixed anxiety-depression of only 1.8% in older community-living residents using standardised psychiatric interviews; this is more similar to our results using criteria other than GADS. Alternatively, the thresholds of the GADS scores may have been set too low as they were based on ‘having a 50% chance of a clinically important disturbance’ [10]. The higher prevalence of depression than anxiety based on either GADS or the SF-36 sub-scale is as expected, although depression is more common at all ages in women than men, and the results may not be generalisable to older males.

The range of scores exhibited on the GADS, and the small proportion of missing data further support the use of the GADS as an acceptable instrument to measure anxiety and depression among older women but it cannot distinguish between these two conditions.

Key points

  • Anxiety and depression in older women may be viewed as a unitary construct.
  • There are qualitative differences in the expression and co-morbidity of anxiety and depression in later life.
  • The GADS is an acceptable instrument that can distinguish between older women with and without mental health problems.

Acknowledgements

The Australian Longitudinal Study on Women's Health, which was conceived and developed by groups of inter-disciplinary researchers at the Universities of Newcastle and Queensland, is funded by the Australian Government Department of Health and Ageing. We thank all participants for their valuable contribution to this project.

Conflicts of interest

None.

Natasha A. Koloski*, Nadine Smith, Nancy A. Pachana and Annette Dobson

School of Psychology, University of Queensland, St Lucia Campus, Brisbane 4072, Australia

* To whom correspondence should be addressed E-mail: koloski{at}psy.uq.edu.au

References

  1. Flint AJ. Epidemiology and comorbidity of the anxiety disorders in the elderly. Am J Psychiatry (1994) 151:640–9.[Abstract/Free Full Text]
  2. Sheikh JI. Anxiety disorders and their treatment. Clin Geriatr Med (1992) 8:411–26.[Medline]
  3. Tucker GJ. Treatment approaches to anxiety, depression and aggression in the elderly. J Clin Psychiatry (1994) 55(Suppl.):3–4.
  4. Weiss KJ. Management of anxiety and depression syndromes in the elderly. J Clin Psychiatry (1994) 55(Suppl.):5–12.[Web of Science][Medline]
  5. Barlow DH, Campbell LA. Mixed anxiety-depression and its implications for models of mood and anxiety disorders. Compr Psychiatry (2000) 41:55–60.[CrossRef][Web of Science][Medline]
  6. Mehta KM, Simonsick EM, Penninx BW, et al. Prevalence and correlates of anxiety symptoms in well-functioning older adults: findings from the health aging and body composition study. J Am Geriatr Soc (2003) 51:499–504.[CrossRef][Web of Science][Medline]
  7. Mackinnon A, Christensen H, Form A, et al. A latent trait analysis of an inventory designed to detect symptoms of anxiety and depression using an elderly community sample. Psychol Med (1994) 24:977–86.[Web of Science][Medline]
  8. Christensen H, Jorm AF, Mackinnon AJ, et al. Age differences in depression and anxiety symptoms: a structural equation modelling analysis of data from a general population sample. Psychol Med (1999) 29:325–39.[CrossRef][Web of Science][Medline]
  9. Goldberg D, Bridges K, Duncan-Jones P, et al. Dimensions of neuroses seen in primary-care settings. Psychol Med (1987) 17:461–70.[Web of Science][Medline]
  10. Goldberg D, Bridges K, Duncan-Jones P, et al. Detecting anxiety and depression in general medical settings. Br Med J (1988) 297:897–9.[Abstract/Free Full Text]
  11. Schoevers RA, Beekman AT, Deeg DJ, et al. Comorbidity and risk-patterns of depression, generalised anxiety disorder and mixed anxiety-depression in later life: results from the AMSTEL study. Int J Geriatr Psychiatry (2003) 18:994–1001.[CrossRef][Web of Science][Medline]
  12. Copeland JRM, Dewey ME, Griffiths-Jones HM. A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT. Psychol Med (1986) 16:89–99.[Web of Science][Medline]
  13. Brown WJ, Bryson L, Byles J, et al. Women's Health Australia: recruitment for a national longitudinal cohort study. Women Health (1998) 28:23–40.[CrossRef][Web of Science][Medline]
  14. Lee C, Dobson AJ, Brown WJ, et al. Cohort profile: The Australian Longitudinal Study on Women's Health. Int J Epidemiol (2005) 34:987–91.[Free Full Text]
  15. McCallum J. The SF-36 in an Australian sample: Validating a new generic health status measure. Aust J Public Health (1995) 9:160–6.
  16. Ware JE Jr, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scores: A User's Manual (1994) Boston, MA: The Health Institute.
  17. Holmes WC. A short, psychiatric, case finding measure for HIV seropositive outpatients: performance characteristics of the 5-item mental health subscale of the SF-20 in a male, seropositive sample. Med Care (1998) 36:237–43.[CrossRef][Web of Science][Medline]
  18. Fraser C, McDonald RP. NOHARM: least squares item factor analysis. Multivariate Behav Res (1988) 23:267–9.[CrossRef][Web of Science]
  19. Finch H. Comparison of the performance of varimax and promax rotations: factor structure recovery for dichotomous items. J Educ Meas (2006) 43:39.[CrossRef]
  20. Clarke D, Mackinnon A, Smith G, et al. Dimensions of psychopathology in the medically ill: a latent trait analysis. Psychosomatics (2000) 41:48–425.

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
37/4/464    most recent
afn091v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Koloski, N. A.
Right arrow Articles by Dobson, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koloski, N. A.
Right arrow Articles by Dobson, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?